2027 年亚太地区药物警戒和药物安全软件市场预测 - 按软件类型划分的 COVID-19 影响和区域分析（不良事件报告软件、药物安全审计软件、问题跟踪软件和完全集成软件）；交付模式（本地和基于云）；最终用户（制药和生物技术公司、合同研究组织 (CRO) 和业务流程外包 (BPO) 公司）
No. of Pages: 129 | Report Code: TIPRE00022770 | Category: Technology, Media and Telecommunications
No. of Pages: 129 | Report Code: TIPRE00022770 | Category: Technology, Media and Telecommunications
药物警戒（PV）通过评估、监测和发现药物相互作用及其作用，在医疗保健系统中发挥着重要作用。对人体的影响。药物警戒帮助公司在试验阶段和上市后期间监测任何药物不良反应事件。
因此，药物警戒的全球化预计将对药物警戒和药物安全软件产生巨大需求。未来几年，预计这将进一步推动药物警戒和药物安全软件市场的发展。
亚太地区国家预计将因 COVID-19 的增长而面临巨大挑战。考虑到经济运行和地理条件，疫情的爆发对亚太低收入国家的医疗旅游业、医疗设备、激光系统、配件制造商以及医疗基础设施短缺带来的其他问题造成了影响。自去年12月中国武汉出现首例病例以来，冠状病毒已传播到至少180个国家和地区。为了防止疾病传播，印度、韩国、新加坡、马来西亚和菲律宾等国已采取限制措施。世卫组织表示，由于受 COVID-19 影响的国家的风险迅速变化，并且不断控制疫情趋势，任何额外的卫生措施都可能会严重干扰国际旅行和贸易。亚太地区的报告标准存在巨大差异。虽然一些国家已采用电子报告，但许多组织仍然使用传统的快递或专人递送方法进行纸质报告或通过光盘进行电子报告。目前，电子报告和电子邮件提交与 COVID-19 兼容。然而，所有方法都需要药物警戒团队、当地法律代表、快递支持和分散在不同地理位置的团队之间进行有效沟通，例如以当地语言进行门户输入。
亚太地区的药物警戒和药物安全软件市场预计将从 2019 年的 3280 万美元增长到 2027 年的 6270 万美元；预计 2020 年至 2027 年复合年增长率为 8.2%。药物不良反应 (ADR) 是一个重要的公共卫生问题，是导致疾病和死亡的重要原因。由于所有药物都有潜在的药物不良反应，因此每当开药时都需要进行风险效益分析。患者或医疗保健专业人员报告的 ADR 有助于安全监测，从而有助于安全有效地使用药物。药品不良反应报告产生的数据量不断增加，需要仔细处理和存储。所有这些数据都有不同的形式、语言、位置等。为了统一排列这些数据，自动化系统/软件会很有帮助。因此，药物不良反应 (ADR) 发生率的上升可能会推动市场的增长。
从软件类型来看，不良事件报告软件细分市场占2019年亚太地区药物警戒和药物安全软件市场份额最大。就交付模式而言，本地部署细分市场在2019年药物警戒和药物安全软件市场中占有较大的市场份额。就最终用户而言，合同2019年，研究组织细分市场在药物警戒和药物安全软件市场中占有较大的市场份额。
< strong>主要来源和上市公司
准备本亚太地区药物警戒和药物安全软件市场报告时提到的一些主要一手和二手来源是公司网站、年报、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有 Veeva Systems
按软件类型
按交付模式< /p>
最终用户 span>
< /p>
按国家/地区
< /p>
Strategic insights for Asia Pacific Pharmacovigilance and Drug Safety Software involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 32.8 Million |
| Market Size by 2027 | US$ 62.7 Million |
| Global CAGR (2020 - 2027) | 8.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 软件类型
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Pharmacovigilance and Drug Safety Software refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Pharmacovigilance and Drug Safety Software Market is valued at US$ 32.8 Million in 2019, it is projected to reach US$ 62.7 Million by 2027.
As per our report Asia Pacific Pharmacovigilance and Drug Safety Software Market, the market size is valued at US$ 32.8 Million in 2019, projecting it to reach US$ 62.7 Million by 2027. This translates to a CAGR of approximately 8.2% during the forecast period.
The Asia Pacific Pharmacovigilance and Drug Safety Software Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Pharmacovigilance and Drug Safety Software Market report:
The Asia Pacific Pharmacovigilance and Drug Safety Software Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Pharmacovigilance and Drug Safety Software Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Pharmacovigilance and Drug Safety Software Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Pharmacovigilance and Drug Safety Software Market
